Erlotinib 00093-7662-56
- Manufacturer
- Teva Pharmaceuticals Usa, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 8, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA091059
Need to source Erlotinib? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Erlotinib Hydrochloride | 25 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Protein Kinase Inhibitors [MoA]
Selected Package
00093-7662-56Selected30 TABLET, FILM COATED in 1 BOTTLE (0093-7662-56)